Pharmaceutical Technology
NICE now recommends Nucala for both severe asthma and COPD, expanding the drug’s clinical uptake across the UK’s public health service.
Pharmaceutical Technology
NICE now recommends Nucala for both severe asthma and COPD, expanding the drug's clinical uptake across the UK's public health service.
Pharmaceutical Technology
NICE now recommends Nucala for both severe asthma and COPD, expanding the drug’s clinical uptake across the UK’s public health service.